Portrazza is a prescription drug used for the treatment of patients with metastatic squamous non-small cell lung cancer. It is a monoclonal antibody that blocks a certain protein in the body to protect the healthy cells from damage. To buy Portrazza 800mg/50ml or to know its price contact 3S Corporation.
Manufacturer : Eli Lilly and Company
Strengths available : 800mg/50ml
Form : Injection
Dosage : Usual Adult Dose for Non-Small Cell Lung Cancer: 800 mg IV over 60 minutes on Days 1 and 8 of each 3-week cycle prior to gemcitabine and cisplatin infusion.
Duration of therapy: Continue until disease progression or unacceptable toxicity.
Storage : Store at 2°C to 8°C
Is the medicine FDA approved : Yes
Date of Approval : November 24, 2015
Common side effects are vomiting, diarrhea, skin rash or low levels of magnesium in your blood.